Prophylaxis in von Willebrand disease with von Willebrand factor concentrate and nonfactor therapies
This manuscript summarizes the current status of prophylaxis and novel potential therapies to prevent bleeding in patients with von Willebrand disease (VWD). VWD is the most common inherited bleeding disorder, which is associated mainly with mucocutaneous bleeding and bleeding during surgical and de...
Saved in:
| Main Authors: | Calvin B. van Kwawegen, Frank W.G. Leebeek |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-11-01
|
| Series: | Research and Practice in Thrombosis and Haemostasis |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2475037924002942 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
von Willebrand Factor (VWF) Inhibitors in Two Brothers with von Willebrand Disease: A Case Report
by: Claudia Djambas Khayat, et al.
Published: (2025-01-01) -
Probing rare von Willebrand disease–causing mutations in the D4 and C-domains of von Willebrand factor
by: Golzar Mobayen, et al.
Published: (2025-05-01) -
Sexuality and bleeding in von Willebrand disease
by: Calvin B. van Kwawegen, et al.
Published: (2025-02-01) -
Efficacy and safety of plasma-derived von Willebrand factor/factor VIII concentrate (wilate) prophylaxis in children and adolescents with von Willebrand disease – WIL-31 study post hoc analysis
by: Robert F. Sidonio, Jr., et al.
Published: (2025-02-01) -
Intraindividual variability of von Willebrand factor and the need for repeated testing
by: Malene Helligsø Kirkeby, et al.
Published: (2025-05-01)